Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives

Welcome and introduction

Date

12 Sep 2022

Session

ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives

Topics

Tumour Site

Breast Cancer

Presenters

Giuseppe Curigliano

Authors

G. Curigliano

Author affiliations

  • Early Drug Development for Innovative Therapies Division, IEO - Istituto Europeo di Oncologia, 20141 - Milan/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A and discussiond

Presenter: All Speakers

Session: ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.